This study evaluated the clinical efficacy of Venoruton (O-(beta-hydroxyethyl)-rutosides) (HR) (Novartis Consumer Healthcare) in subjects with severe chronic venous insufficiency (CVI).

Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study / M.R. Cesarone, G. Belcaro, E. Ippolito, L. Pellegrini, A. Ledda, R. Luzzi, A. Ricci, M. Dugall, P. Bavera, M. Hosoi, S. Stuard, M. Corsi. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - 52:2 Suppl 1(2010 Jun), pp. 43-48.

Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study

E. Ippolito;
2010

Abstract

This study evaluated the clinical efficacy of Venoruton (O-(beta-hydroxyethyl)-rutosides) (HR) (Novartis Consumer Healthcare) in subjects with severe chronic venous insufficiency (CVI).
Hydroxyethylrutoside; Stockings, Compression; Humans; Aged; Laser-Doppler Flowmetry; Registries; Blood Pressure Monitoring, Ambulatory; Cost-Benefit Analysis; Venous Insufficiency; Adult; Chronic Disease; Middle Aged; Microcirculation; Female; Male
Settore MED/22 - Chirurgia Vascolare
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/210120
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 5
  • ???jsp.display-item.citation.isi??? ND
social impact